Cooper C. Collins, Chief Strategic Officer, 10% Owner at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 23,364 shares at $2.51 ($58K) on 2013-10-08, disclosed to the SEC on 2013-10-08.
Scheduled sale ($58k) by Chief Strategic Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.45 | 10,785 | $26K | 45.8% |
| 2 | $2.49 | 12,379 | $31K | 53.4% |
| 3 | $2.51 | 200 | $502 | 0.9% |
| Total | $2.47 avg | 23,364 | $58K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |